Home>News & Events>Press Releases>D-RSC

News & Events

  • January 22, 2018

    Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker

     Tucson, AZ — January 22, 2018 — Critical Path Institute (C-Path) announced today that the European Medicines Agency (EMA) has issued a Letter of Support for measurement of glutamate dehydrogenase (GLDH) as a biomarker of hepatocellular liver injury. The letter was awarded to C-Path’s Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC)......
  • October 18, 2017

    C-Path and CDISC Announce Therapeutic Area User Guide for Duchenne Muscular Dystrophy

     October 18, 2017     TUCSON, Ariz., and AUSTIN, Texas – October 18, 2017 –Critical Path Institute (C-Path) and The Clinical Data Interchange Standards Consortium (CDISC) announce the open availability of a Duchenne Muscular Dystrophy Therapeutic Area User Guide (TAUG-DMD v1.0), which describes the most common clinical concepts relevant to Duchenne studies using the CDISC standard format. This format......
  • August 3, 2015

    Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy

     August 3, 2015 Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy Tucson, Arizona – August 3, 2015: Critical Path Institute (C-Path), a pioneering non-profit organization dedicated to accelerating the pace and reducing the costs of medical product development, announced the formation of its tenth consortium: The Duchenne Regulatory Sciences Consortium (D-RSC). In......
Refine:

Period

Program

  • All Programs
  • CPAD - Critical Path For Alzheimer's Disease
  • TTC - Transplant Therapeutics Consortium
  • T1D - Type 1 Diabetes Consortium
  • HD-RSC - Huntington’s Disease Regulatory Science Consortium
  • RDCA-DAP - Rare Disease Cures Accelerator-Data and Analytics Platform
  • TOMI-T1D - Trial Outcome Markers Initiative in T1D
  • QuantMed - Quantitative Medicine Program
  • PredicTox KE - PredicTox Knowledge Environment
  • CDRC - CURE Drug Repurposing Collaboratory
  • SHIP-MD - System of Hospitals for Innovation in Pediatrics – Medical Devices
  • CPTA - Critical Path to Therapeutics for the Ataxias
  • CP-SCD - Critical Path for Sickle Cell Disease
  • RD-COA Consortium - Rare Disease Clinical Outcome Assessment Consortium
  • TRxA - Translational Therapeutics Accelerator
  • CP-RND - Critical Path for Rare Neurodegenerative Diseases
  • CPA-1 - Critical Path for Alpha-1 Antitrypsin Deficiency
  • CFAST - Coalition For Accelerating Standards and Therapies
  • BmDR - Biomarker Data Repository
  • CPP - Critical Path for Parkinson's
  • CPTR - Critical Path to TB Drug Regimens
  • DCC - Data Collaboration Center
  • D-RSC - Duchenne Regulatory Science Consortium
  • INC - International Neonatal Consortium
  • MSOAC - Multiple Sclerosis Outcome Assessments Consortium
  • PKD - Polycystic Kidney Disease Outcomes Consortium
  • PRO Consortium - Patient-Reported Outcome Consortium
  • eCOA Consortium - Electronic Clinical Outcome Assessment Consortium
  • PSTC - Predictive Safety Testing Consortium
  • PTC - Pediatric Trials Consortium
  • TB-PACTS - TB-Platform for Aggregation of Clinical TB Studies

Category

Tags

x